UBS AM’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-65,534
Closed -$3.85M 2585
2023
Q4
$3.85M Sell
65,534
-232,660
-78% -$13.7M ﹤0.01% 1375
2023
Q3
$13M Sell
298,194
-4,627
-2% -$202K 0.01% 870
2023
Q2
$11.3M Hold
302,821
0.01% 925
2023
Q1
$11.3M Buy
302,821
+62,919
+26% +$2.34M 0.01% 925
2022
Q4
$10.9M Buy
239,902
+37,976
+19% +$1.72M 0.01% 910
2022
Q3
$14.1M Sell
201,926
-15,493
-7% -$1.08M 0.01% 857
2022
Q2
$14.6M Sell
217,419
-70,241
-24% -$4.72M 0.01% 821
2022
Q1
$23.7M Sell
287,660
-247,405
-46% -$20.3M 0.01% 799
2021
Q4
$78.5M Buy
535,065
+128,065
+31% +$18.8M 0.03% 533
2021
Q3
$72M Sell
407,000
-23,751
-6% -$4.2M 0.03% 539
2021
Q2
$69.6M Sell
430,751
-33,339
-7% -$5.39M 0.03% 550
2021
Q1
$79.5M Sell
464,090
-27,926
-6% -$4.78M 0.04% 482
2020
Q4
$108M Sell
492,016
-154,280
-24% -$33.9M 0.05% 382
2020
Q3
$107M Buy
646,296
+41,646
+7% +$6.92M 0.06% 321
2020
Q2
$69M Buy
604,650
+6,187
+1% +$706K 0.04% 400
2020
Q1
$46M Buy
598,463
+233,931
+64% +$18M 0.03% 462
2019
Q4
$47M Buy
364,532
+128,939
+55% +$16.6M 0.03% 545
2019
Q3
$18.4M Buy
235,593
+213,716
+977% +$16.7M 0.01% 786
2019
Q2
$2.25M Buy
21,877
+11,117
+103% +$1.15M ﹤0.01% 1532
2019
Q1
$789K Buy
10,760
+3,880
+56% +$284K ﹤0.01% 1906
2018
Q4
$292K Sell
6,880
-2,220
-24% -$94.2K ﹤0.01% 2223
2018
Q3
$429K Buy
9,100
+300
+3% +$14.1K ﹤0.01% 2151
2018
Q2
$434K Buy
+8,800
New +$434K ﹤0.01% 2158